Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Product Specifications CAS Numbers: CJC-1295 No DAC: 863288-34-0 Ipamorelin: 170851-70-4 Peptide Sequences: CJC-1295 No DAC (MOD-GRF 1-29): TyrD-AlaAspAlaIlePheThrGlnSerTyrArgLysValLeuAlaGlnLeuSerAlaArgLysLeuLeuGlnAspIleLeuSerArg Ipamorelin: AibHisD-2-NalD-PheLysNH Purity: Typically 95% (verified by HPLC and mass spectrometry) Packaging Format: Lyophilized powder, combined total of 10 mg per vial (5 mg each peptide) Storage Conditions: Store at 20 C
Archived from the original on 18 December 2023
Indications and Usage Ozempic (semaglutide) tablets 4 mg or 9 mg and Rybelsus (semaglutide) tablets 7 mg or 14 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events Important Safety Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Weight monitoring serves multiple purposes in the post-operative period
